Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,871 Cr
Revenue (TTM)
₹392 Cr
Net Profit (TTM)
₹75 Cr
ROE
19.6 %
ROCE
25.2 %
P/E Ratio
25
P/B Ratio
4.3
Industry P/E
--
EV/EBITDA
12.7
Div. Yield
0.2 %
Debt to Equity
0
Book Value
₹97.2
EPS
₹21.2
Face value
2
Shares outstanding
44,669,355
CFO
₹459.61 Cr
EBITDA
₹615.83 Cr
Net Profit
₹284.29 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vimta Labs
| -30.8 | -14.4 | -29.3 | -24.2 | 40.7 | 38.8 | 28.8 |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vimta Labs
| 22.4 | 145.3 | -7.5 | 6.7 | 135.2 | 88.4 | -71.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vimta Labs
|
418.8 | 1,870.5 | 392.5 | 74.7 | 24.2 | 19.1 | 25 | 4.3 |
| 635.5 | 35,564.9 | 1,844.6 | 451.3 | -- | 21 | 78.8 | 12.5 | |
| 636.2 | 32,981.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 100.9 | 7.2 | |
| 423.5 | 13,410.5 | 1,976.2 | 160.7 | 14.1 | 6.7 | 106.4 | 6.8 | |
| 1,325.4 | 22,213.6 | 2,662.8 | 533.1 | 22.9 | 24.1 | 42 | 8.7 | |
| 102.4 | 133.1 | 0.0 | -0.2 | -- | -2.8 | -- | 16.0 | |
| 63.0 | 125.5 | 50.3 | -2.1 | -3.3 | -6.3 | -- | 1.9 | |
| 657.6 | 26,355.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 87.6 | 11.3 | |
| 1,823.8 | 9,460.1 | 1,566.5 | 169.5 | 14.8 | 12.7 | 56.2 | 6.4 | |
| 1,103.8 | 11,233.0 | 1,613.3 | 259.9 | 23.0 | 17.3 | 43.6 | 7.1 |
1 min read•By Research Desk
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research,... and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India. Read more
Incorporated
1990
Chairman
Sivalinga Prasad Vasireddi
Managing Director
Harita Vasireddi
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Vimta Labs Ltd is ₹418.80 (NSE) and ₹418.75 (BSE) as of 19-Mar-2026 IST. Vimta Labs Ltd has given a return of 40.73% in the last 3 years.
The P/E ratio of Vimta Labs Ltd is 25.03 times as on 19-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
33.31
|
5.98
|
|
2024
|
24.04
|
3.15
|
|
2023
|
14.44
|
2.52
|
|
2022
|
16.86
|
3.01
|
|
2021
|
16.63
|
1.83
|
The 52-week high and low of Vimta Labs Ltd are Rs 902.65 and Rs 400.30 as of 19-Mar-2026.
Vimta Labs Ltd has a market capitalisation of ₹ 1,871 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vimta Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-12.90
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.